At a highly anticipated conference this year, Dr. Katsu Taka
At a highly anticipated conference this year, Dr. Katsu Takahashi, the pioneering Japanese dentist and scientist, officially announced the launch of new human clinical trials for his groundbreaking tooth regeneration drug. Backed by years of research and development in biomimetic science, this innovation is being brought to reality through Toregem Biopharma, the biotech startup co-founded by Dr. Takahashi to bridge laboratory success and real-world dental care.
The announcement drew global attention, as it offers hope to millions suffering from congenital tooth loss, trauma-related tooth absence, and severe dental diseases. For the first time, the possibility of regrowing natural human teeth rather than replacing them with artificial solutions is moving closer to everyday clinical practice.
https://youtu.be/jskELK0KTbg?si=VXktFKu5iDtWkQBy
Comments
No comments yet.